Dr. Mercola's Censored Library (Private Membership)

Share this post

FDA Gives Accelerated Approval for Risky Alzheimer’s Pill

takecontrol.substack.com

FDA Gives Accelerated Approval for Risky Alzheimer’s Pill

The Alzheimer's medication Leqembi received fast-tracked approval even though it causes life-threatening adverse events and is targeting a component of the disease that many believe is misunderstood.

Dr. Joseph Mercola
Jan 25, 2023
∙ Paid
12
Share this post

FDA Gives Accelerated Approval for Risky Alzheimer’s Pill

takecontrol.substack.com
Share
fda gives approval for risky alzheimers pill

STORY AT-A-GLANCE

  • The U.S. Food and Drug Administration (FDA) granted accelerated approval for the Alzheimer’s disease drug lecanemab (Leqembi)

  • The drug, a monoclonal antibody, binds to amyloid beta in the brain

  • The most common reactions included amyloid-related imaging abnormalities, or ARIA, which involves swelling and bleeding in the brain that can be l…

Keep reading with a 7-day free trial

Subscribe to

Dr. Mercola's Censored Library (Private Membership)
to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2023 Dr. Joseph Mercola
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing